The expression of aberrant glycans structures in cancer cells has been shown to play an instrumental role in each pathophysiological step of cancer development and progression [8].This review describes how glycans integrate with the insulin/IGF system that include the specific ligands, receptors and signaling pathways, addressing how this biological network affects and controls cell behaviour, drug resistance and metabolism in cancer. This evidence concerns the gene IGF1 and cancer.